午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

南通全益生物科技有限公司 公司信息

公司名稱: 南通全益生物科技有限公司
電話: 0513-66337626
電子郵件:sales@chemhifuture.com
國籍:中國
網(wǎng)址: https://www.chemhifuture.com/
產(chǎn)品總數(shù):5686
52 53 54 55 56 57

公司提供產(chǎn)品列表

PF-06372222 1407592-99-7
3-(5-bromo-1H-indol-3-yl)-2,2-dimethylpropyl acetate 2641451-61-6
Mito-TRFS
TRFS-red
Balomenib 2939850-17-4
Aleniglipron/GSBR-1290 2685823-26-9
Thiamine Triphosphate 3475-65-8
Glycerylphosphorylcholine 563-24-6
iBFAR2 353484-02-3
Quisinostat (JNJ-26481585) 875320-29-9
IPG-1 AM 1369302-18-0
Glycerophosphoinositol choline 425642-32-6
KDOAM25 2230731-99-2
Colibactin 742 2916559-62-9
(9s,10s)-9,10-Dihydro-9,10-[1,2]benzenoanthracene-1,4-diol 5969-70-0
AG-7404 343565-99-1
1110768-13-2 1110768-13-2
3-[(2S)-2-amino-3-methylbutanamido]propane-1-sulfonic acid 1034190-08-3
2'-chloro-5'-methoxy-6-methyl-[4,4'-bipyridine]-3-carboxylic acid 2'-氯-5'-甲氧基-6-甲基-[4,4'-聯(lián)吡啶]-3-甲酸 2782812-46-6
ATR-IN-29 2761193-67-1
Clerosterol 2364-23-0
Ivonescimab 2428381-53-5
11-cis Retinoic Acid 68070-35-9
ML307
STING agonist-29 2868261-51-0
GNE7599 2771069-76-0
Trastuzumab emtansine 曲妥珠單抗 1018448-65-1
Pembrolizumab (anti-PD-1)
RIBI-529 216014-46-9
KRASG12D-IN-3 3033638-63-7
Fluotrimazol 31251-03-3
Linustedastatum 2254299-48-2
AG-041R 159883-95-1
DGN549-C 2058075-34-4
Isoleucyl tRNA synthetase-IN-2 2494195-61-6
rac-5-Methyl Tetrahydropteroic Acid Sodium Salt 4349-41-1
Nicorandil Impurity 16 1157-74-0
(S)-2-(((Benzyloxy)carbonyl)amino)-2-((tert-butoxycarbonyl)amino)acetic acid 1932778-68-1
Zurletrectinib/ICP-723 2403703-30-8
KRASG12D-IN-3-d3 3033638-69-3
RP03707 3030493-05-8
HRS-4642 2836263-09-1
65141-56-2 65141-56-2
Dihydroxanthopterin 1131-35-7
GIP/GLP-1 dual receptor agonist-1 2807481-02-1
Epyrifenacil 353292-31-6
L18-MDP 60398-08-5
Menin-MLL inhibitor-22 2851841-61-5
tert-butyl 4-[5-bromo-6-[(1S)-1-methoxyethyl]pyridin-3-yl]piperazine-1-carboxylate 2641824-76-0
Obatoclax 803712-67-6
(R)-2-(1-amino-2-(2,5-dibromophenyl)ethyl)-5-bromopheno 1585969-24-9
23-Oxa-OSW-1 790224-37-2
GDC-2394 2238822-08-5
ITK degrader 2 2858738-65-3
2714410-97-4 2714410-97-4
VT02956 2999763-09-4
BMV109 1458731-58-2
Elsibucol 216167-95-2
BWC0977 2254567-00-3
3-((5-Bromopyridin-2-yl)oxy) 189954-65-2
SR 142948 184162-64-9
Ledaborbactam etzadroxil 1842399-68-1
Abemaciclib metabolite M18 2704316-81-2
Fenoterol hydrobromide 1944-12-3
Natalizumab 那他珠單抗 189261-10-7
Imdevimab 伊姆德維馬布
ASP3082
Duvyzat 497833-27-9
OG-L002 1357302-64-7
Mitoquinol 845959-55-9
Tezepelumab 特折魯單抗 1572943-04-4
Trastuzumab Deruxtecan 德盧替康-曲妥珠單抗 1826843-81-5
Mepolizumab 美泊麗單抗 196078-29-2
Ocrelizumab 奧克立珠單抗 637334-45-3
Dupliumab 度匹魯單抗 1190264-60-8
Tocilizumab 托珠單抗 375823-41-9
Pertuzumab 帕妥珠單抗 380610-27-5
AUR-1545 3031593-79-7
AMrubicin hydrochloride 92470-31-0
Epitinib 1203902-67-3
Sarilumab 1189541-98-7
Risankizumab 瑞莎珠單抗
Benralizumab 貝那利珠單抗 1044511-01-4
Org 25543 363628-88-0
Aducanumab 阿杜那單抗 1384260-65-4
Efmoroctocog alfa 1270012-79-7
Anti-MouseVEGFR-2Antibody(DC101)
(R)-8-Cyclopentyl-2-((1-(2-((3R,5S)-3,5-dimethylpiperazin-1-yl)acetyl)-6-methoxyindolin-5-yl)amino)-7-ethyl-5-methyl-7,8-dihydropteridin-6(5H)-one 3063893-60-4
Ramucirumab (anti-VEGFR) 947687-13-0
Panitumumab 帕尼單抗 339177-26-3
Casirivimab 卡西里維馬布
Lecanemab 侖卡奈單抗 1260393-98-3
5-TMRIA [Tetramethylrhodamine-5-Iodoacetamide Dihydroiodide 114458-99-0
Alemtuzumab 阿倫單抗 216503-57-0
Benzoquinazolinone 12 1227923-91-2
DRF-1042 200619-13-2
Emicizumab 艾米珠單抗 1610943-06-0
PROTAC BTK Degrader-12 2736508-65-7
Cytochalasin D/Zygosporin A/NSC 209835 細胞松弛素D 22144-77-0
(E)-2-Hydroxyoctadec-9-enoic acid 56472-31-2
52 53 54 55 56 57
Copyright 2007? ChemicalBook. All rights reserved.